Agilent Technologies partners with Science Exchange

| By | Drug Development, R&D

Agilent Technologies, an American public research, development and manufacturing company, announced a partnership with Science Exchange, the world’s leading enterprise platform for outsourced research and development services. The partnership will promote access to Agilent-enabled services to the research community worldwide.

Central to the partnership with Science Exchange is the Agilent-Science Exchange portal that allows Agilent customers to search and request a quote for Agilent-enabled research services directly from Science Exchange’s ISO-9001 certified verification program is employed to qualify each listed provider, and the platform incorporates industry-leading data security infrastructure so that Agilent customers can utilize the portal with confidence.

“Efficient access to providers with unique technology is increasingly at the core of R&D strategy across our industry, particularly as returns on R&D investments have come into question in recent years,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “We are excited to partner with Agilent to extend the Science Exchange enterprise platform and to provide immediate access to hundreds of qualified providers offering Agilent-enabled services.”

Agilent and Science Exchange will co-market the new portal beginning in February 2018 and will collaborate to analyze utilization trends of both service providers and Agilent products.

SOURCE: agilent
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.